Skip to Main Content

Paper Details

Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality: a prospective study.
Diabetologia
14
2020
CAD, CC, CVD, Diabetes, GIP, GIP receptor, GIP-associated genetic variant, GIPR, GLP-1, Glucose, Glucose-dependent insulinotropic peptide, MDC, Malm Diet Cancer, cardiovascular disease, cardiovascular events, coronary artery disease, genetic risk variants, glucagon-like peptide 1, glucose, glucose-dependent insulinotropic peptide, myocardial infarction, rs1800437
Author NameAffiliation
Peter M NilssonLund University
Peter AlmgrenLund University
Peter AlmgrenLund University Diabetes Centre, Lund University
Liisa HakasteFolkhalsan Research Centre
Liisa HakasteUniversity of Helsinki
Liisa HakasteHelsinki University Hospital
Liisa HakasteFinnish Institute of Molecular Medicine, University of Helsinki
Tiinamaija TuomiFolkhalsan Research Centre
Tiinamaija TuomiUniversity of Helsinki
Tiinamaija TuomiHelsinki University Hospital
Tiinamaija TuomiFinnish Institute of Molecular Medicine, University of Helsinki
Paul W FranksLund University
Paul W FranksDepartment of Public Health & Clinical Medicine, Umea University
Paul W FranksHarvard School of Public Health
Rashmi B PrasadLund University
Rashmi B PrasadLund University Diabetes Centre, Lund University
Olle MelanderLund University
Leif GroopLund University
Leif GroopLund University Diabetes Centre, Lund University
Leif GroopHelsinki University Hospital
Emma AhlqvistLund University
Emma AhlqvistLund University Diabetes Centre, Lund University
  • 1 - 22

Datasets

Release 1.2